| Announce Date | 02/03/2026 |
| EPS Normalized Actual | $-1.08 (Beat by $0.16) |
| EPS GAAP Actual | $-1.08 (Beat by $0.16) |
| Revenue Actual | $10.3668B |
| Revenue Surprise | Beat by $10366.8M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.2161 | 91.44 | 0.16656 | 0.2537 | 1 |
| Dec 2028 | 0.11 | 179.64 | 0.08482697 | 0.12752 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0 | 0 | 10.3668B | 100% | 10366.8M |
| FQ3 2025 (Sep 2025) | 0 | 0 | 28.4019B | 100% | 28401.9M |
| FQ2 2025 (Jun 2025) | 0.1 | 0.1 | 8.66156B | 100% | 8661.56M |
| FQ1 2025 (Mar 2025) | -2.36 | -2.36 | 12.9762B | 100% | 12976.2M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 0B | NAN% | 0M |
| FQ1 2024 (Mar 2024) | 1.01 | 1.01 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | -0.4 | -0.4 | 0B | NAN% | 0M |
| FQ3 2024 (Sep 2024) | -0.13 | -0.13 | 0B | NAN% | 0M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 0.1362 | -- | 0.10531 | 0.15898 | 3 |
| FQ3 2029 (Sep 2029) | 0.0392 | -- | 0.03030946 | 0.04575728 | 3 |
| FQ2 2029 (Jun 2029) | 0.0713 | -- | 0.05512919 | 0.0832269 | 3 |
| FQ1 2029 (Mar 2029) | -0.0354 | -- | -0.04132163 | -0.02737129 | 3 |
| FQ4 2028 (Dec 2028) | 0.0182 | -- | 0.01407225 | 0.02124445 | 3 |
| FQ3 2028 (Sep 2028) | -0.0982 | -- | -0.11463 | -0.07592828 | 3 |
| FQ2 2028 (Jun 2028) | -0.0683 | -- | -0.07972506 | -0.05280959 | 3 |
| FQ1 2028 (Mar 2028) | -0.1191 | -- | -0.13902 | -0.09208817 | 3 |
| FQ4 2027 (Dec 2027) | 0.23125 | -- | 0.1788 | 0.26993 | 2 |
| FQ3 2027 (Sep 2027) | 0.17467 | -- | 0.13505 | 0.20389 | 2 |
| FQ2 2027 (Jun 2027) | 0.15053 | -- | 0.11639 | 0.17571 | 2 |
| FQ1 2027 (Mar 2027) | 0.028117 | -- | 0.02174008 | 0.03282035 | 2 |
| FQ4 2026 (Dec 2026) | -0.044042 | -- | -0.05140924 | -0.03405329 | 3 |
| FQ3 2026 (Sep 2026) | -0.075146 | -- | -0.08771625 | -0.05810292 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 47.19B | -- | 38.95B | 53.26B | 2 |
| FQ3 2029 (Sep 2029) | 45.05B | -- | 37.19B | 50.84B | 2 |
| FQ2 2029 (Jun 2029) | 43.16B | -- | 35.63B | 48.71B | 2 |
| FQ1 2029 (Mar 2029) | 41.26B | -- | 34.06B | 46.57B | 2 |
| FQ4 2028 (Dec 2028) | 39.6B | -- | 32.69B | 44.7B | 1 |
| FQ3 2028 (Sep 2028) | 36.43B | -- | 30.07B | 41.11B | 1 |
| FQ2 2028 (Jun 2028) | 33.56B | -- | 27.7B | 37.87B | 1 |
| FQ1 2028 (Mar 2028) | 30.66B | -- | 25.31B | 34.6B | 1 |
| FQ4 2027 (Dec 2027) | 21.02B | -- | 17.35B | 23.73B | 2 |
| FQ3 2027 (Sep 2027) | 19.51B | -- | 16.11B | 22.02B | 2 |
| FQ2 2027 (Jun 2027) | 19.55B | -- | 16.14B | 22.07B | 2 |
| FQ1 2027 (Mar 2027) | 18.66B | -- | 15.41B | 21.06B | 2 |
| FQ4 2026 (Dec 2026) | 15.75B | 34.18 | 13B | 17.78B | 2 |
| FQ3 2026 (Sep 2026) | 14.81B | -91.83 | 12.22B | 16.71B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
3
EPS # of in-lines
3
Revenue # of Beats
4
Revenue # of Misses
0
Revenue # of in-lines
4
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0 | 0 | NAN% | |
| FQ3 2025 (Sep 2025) | 0 | 0 | NAN% | |
| FQ2 2025 (Jun 2025) | 0.1 | 0.1 | 100% | |
| FQ1 2025 (Mar 2025) | -2.36 | -2.36 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 1.01 | 1.01 | 100% | |
| FQ2 2024 (Jun 2024) | -0.4 | -0.4 | 100% | |
| FQ3 2024 (Sep 2024) | -0.13 | -0.13 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $10.37B | $10366.8M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $28.4B | $28401.9M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $8.66B | $8661.56M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $12.98B | $12976.2M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |